Spherics engages in developing and manufacturing oral pharmaceutical products.
As of August 4, 2008, Spherics, Inc. went out of business. Spherics, Inc., a pharmaceutical company, engages in developing and manufacturing oral pharmaceutical products for central nervous system conditions, gastrointestinal disorders, and cancer. It develops oral systems based on the application of bioadhesive polymers to oral dosage forms. The company also provides products for neurological disorders, such as Alzheimer's, Parkinson's, and multiple sclerosis, as well as for stroke, epilepsy, chronic pain, and migraine. The company was founded in 1997 and is headquartered in Mansfield, Massachusetts.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
May 13, 2005 | Series C | $26.40M | 1 | Advent International | — | Detail |
Aug 16, 2002 | Series B | $10M | 2 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Advent International | Yes | Series C |
POD Holding | — | Series B |
Eastman Ventures | — | Series B |